2044276-16-4

2044276-16-4 structure

Name: Glycolithocholic Acid-d4 MaxSpec® Standard
Chemical Name: Glycolithocholic Acid-d4 MaxSpec® Standard
CAS Number: 2044276-16-4
Molecular Formula: C₂₆H₃₉D₄NO₄
Molecular Weight: 437.649
Catalog: Research Areas Inflammation/Immunology
Create Date: 2021-07-21 17:59:46
Modify Date: 2024-01-09 09:52:36
Glycolithocholic acid-d4 is the deuterium labeled Glycolithocholic acid. Glycolithocholic acid, an endogenous metabolite, is a glycine-conjugated secondary bile acid and can be used to diagnose ulcerative colitis (UC), non-alcoholic steatohepatitis (NASH) and primary sclerosing cholangitis (PSC) [1][2][3][4].

Name	Glycolithocholic Acid-d4 MaxSpec® Standard
Synonyms	MFCD06658889 Glycine, N-[(3α,5β)-3-hydroxy-24-oxocholan-24-yl-2,2,4,4-d4]- N-[(3α,5β)-3-Hydroxy-24-oxo(2,2,4,4-2H4)cholan-24-yl]glycine Glycolithocholic Acid-d4

Description	Glycolithocholic acid-d4 is the deuterium labeled Glycolithocholic acid. Glycolithocholic acid, an endogenous metabolite, is a glycine-conjugated secondary bile acid and can be used to diagnose ulcerative colitis (UC), non-alcoholic steatohepatitis (NASH) and primary sclerosing cholangitis (PSC) [1][2][3][4].
Related Catalog	Signaling Pathways >> Others >> Others Research Areas >> Inflammation/Immunology Research Areas >> Metabolic Disease
In Vitro	Glycolithocholic acid, an endogenous metabolite, is a glycine-conjugated secondary bile acid and can be used to diagnose ulcerative colitis (UC), non-alcoholic steatohepatitis (NASH) and primary sclerosing cholangitis (PSC) [1][2][3][4].
References	[1]. Tanno N, et, al. Biliary lipid composition in heterozygous familial hypercholesterolemia and influence of treatment with probucol. Dig Dis Sci. 1994 Jul;39(7):1586-91. [2]. Ang ZH, et, al. Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis. World J Gastroenterol. 2021 Jun 28;27(24):3609-3629. [3]. Bansal S, et, al. Inhibition of Human Sulfotransferase 2A1-Catalyzed Sulfonation of Lithocholic Acid, Glycolithocholic Acid, and Taurolithocholic Acid by Selective Estrogen Receptor Modulators and Various Analogs and Metabolites. J Pharmacol Exp Ther. 2019 Jun;369(3):389-405. [4]. Sanyal AJ, et, al. Potent suppression of hydrophobic bile acids by aldafermin, an FGF19 analogue, across metabolic and cholestatic liver diseases. JHEP Rep. 2021 Feb 19;3(3):100255.

Density	1.1±0.1 g/cm3
Boiling Point	619.7±30.0 °C at 760 mmHg
Molecular Formula	C₂₆H₃₉D₄NO₄
Molecular Weight	437.649
Flash Point	328.6±24.6 °C
Exact Mass	437.344330
LogP	5.58
Vapour Pressure	0.0±4.1 mmHg at 25°C
Index of Refraction	1.533

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

2044276-16-4	2410279-94-4
1207294-24-3	1332881-65-8
2044276-17-5	1069132-37-1
474-74-8	24404-83-9
15324-64-8	1622429-53-1
1545603-01-7	1582753-92-1
1601988-41-3	1603462-04-9
1802152-71-1	1896548-23-4
1889918-71-1	2751964-57-3
1899014-87-9	1894127-51-5